A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
FDA Lifts REMS Requirement for CAR-T Cell Cancer Therapies
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 



